HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen R Walsh Selected Research

N-(2-cyanoethylene)urea (BA 1)

1/2023Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
10/2022A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
7/2022SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen R Walsh Research Topics

Disease

15COVID-19
02/2024 - 01/2021
10Infections
10/2023 - 04/2003
6Vaccinia
01/2023 - 05/2010
4Pain (Aches)
01/2024 - 01/2020
2Headache (Headaches)
10/2021 - 01/2020
2Fatigue
01/2020 - 01/2020
2Smallpox (Variola)
08/2011 - 08/2009
2Neoplasms (Cancer)
08/2011 - 04/2003
1Anaphylaxis (Anaphylactic Shock)
03/2024
1Erythema
01/2024
1Injection Site Reaction
11/2023
1Rubella (German Measles)
12/2021
1Exanthema (Rash)
12/2021
1Measles
12/2021
1Mumps
12/2021
1HIV Infections (HIV Infection)
01/2020
1Chills
01/2020
1Myalgia
01/2020
1Zika Virus Infection
10/2018
1Inflammation (Inflammations)
02/2015
1Fowlpox
12/2012
1Sepsis (Septicemia)
11/2011
1Peritonitis
11/2011
1Critical Illness (Critically Ill)
11/2011
1Communicable Diseases (Infectious Diseases)
08/2011
1Necrotizing Fasciitis
07/2004

Drug/Important Bio-Agent (IBA)

23VaccinesIBA
03/2024 - 04/2003
4Combined VaccinesIBA
11/2023 - 10/2020
4Neutralizing AntibodiesIBA
11/2022 - 12/2012
3Hydroxychloroquine (Plaquenil)FDA LinkGeneric
02/2024 - 01/2021
3Chloroquine (Aralen)FDA LinkGeneric
02/2024 - 01/2021
3N-(2-cyanoethylene)urea (BA 1)IBA
01/2023 - 07/2022
2Monoclonal AntibodiesIBA
01/2023 - 10/2021
2Proteins (Proteins, Gene)FDA Link
11/2022 - 08/2009
22019-nCoV Vaccine mRNA-1273IBA
11/2022 - 10/2022
2AntigensIBA
02/2015 - 04/2003
2ACAM3000IBA
05/2010 - 05/2010
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2024
1Nucleic AcidsIBA
11/2023
1NVX-CoV2373 adjuvated lipid nanoparticleIBA
10/2023
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023
1N-acetyltalosaminuronic acid (NAT)IBA
01/2023
1DNA VaccinesIBA
01/2023
1COVID-19 VaccinesIBA
01/2023
1Messenger RNA (mRNA)IBA
11/2022
1mRNA-1273.214 COVID-19 vaccineIBA
10/2022
1mRNA VaccinesIBA
07/2022
1Attenuated VaccinesIBA
12/2021
1Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA
12/2021
1ElementsIBA
12/2021
1Rubella VaccineIBA
12/2021
1Broadly Neutralizing AntibodiesIBA
01/2021
1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
06/2013
1AIDS VaccinesIBA
12/2012
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2011
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2011
1Tight Junction ProteinsIBA
11/2011
1EpitopesIBA
08/2009
1Peptides (Polypeptides)IBA
08/2009
1Histocompatibility Antigens Class IIBA
08/2009
1Clindamycin (Cleocin)FDA LinkGeneric
07/2004

Therapy/Procedure

2Injections
01/2024 - 01/2019
1Contraindications
10/2023
1Hematopoietic Stem Cell Transplantation
07/2023
1Drug Therapy (Chemotherapy)
01/2022
1Therapeutics
12/2021
1Intravenous Injections
10/2021
1Intravenous Administration
01/2021
1Critical Care (Surgical Intensive Care)
11/2011
1Investigational Therapies (Experimental Therapy)
04/2003
1Immunotherapy
04/2003